BENGALURU (Reuters) – India has received an offer from Russia to conduct a trial and manufacture its “Sputnik-V” COVID-19 vaccine, with several Indian companies currently studying the proposal, an Indian government official said on Tuesday.
“The government of India attaches great importance to this offer of partnership from a friend,” said V. K. Paul, member of the Indian federal government think-tank NITI Aayog.
The outcome of discussions on the offer were expected soon, he added.
Reporting by Derek Francis in Bengaluru; editing by David Evans
Our Standards:The Thomson Reuters Trust Principles.
source: reuters.com